• LAST PRICE
    233.3600
  • TODAY'S CHANGE (%)
    Trending Down-0.0300 (-0.0129%)
  • Bid / Lots
    224.0000/ 4
  • Ask / Lots
    240.0000/ 1
  • Open / Previous Close
    235.3500 / 233.3900
  • Day Range
    Low 232.4000
    High 240.0400
  • 52 Week Range
    Low 119.7604
    High 299.9800
  • Volume
    179,931
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 233.39
TimeVolumeMDGL
09:32 ET1908240.04
09:34 ET109235.5
09:36 ET100235.5
09:43 ET219235.36
09:50 ET509234.675
09:52 ET100235.54
09:57 ET400234.59
10:03 ET694232.61
10:06 ET700233.65
10:08 ET300234.445
10:14 ET944234.65
10:15 ET700234.4
10:19 ET200233.57
10:26 ET100233.57
10:28 ET100233.75
10:32 ET200234.285
10:35 ET413232.98
10:37 ET100232.98
10:46 ET200233.27
10:48 ET200233.75
10:50 ET300233.51
10:51 ET300234.06
10:53 ET200233.41
11:00 ET1147233.665
11:02 ET100234.58
11:04 ET100234.58
11:06 ET200234.96
11:08 ET466235.93
11:09 ET612236.2
11:11 ET300237.09
11:13 ET1352236.59
11:20 ET300236.62
11:22 ET100236.75
11:24 ET600237.145
11:26 ET228237.83
11:27 ET400238.15
11:29 ET100238.77
11:31 ET384238.96
11:33 ET100239.05
11:36 ET300239.15
11:38 ET200238.4
11:40 ET1898238.87
11:44 ET200238.645
11:45 ET100238.845
11:47 ET200238.27
11:49 ET15935239.235
11:54 ET200239.305
11:58 ET100239.5
12:00 ET100238.98
12:02 ET1100239.22
12:03 ET406238.88
12:05 ET900239
12:07 ET1600239
12:09 ET200239.48
12:12 ET412238.845
12:14 ET1880238.91
12:16 ET100238.695
12:18 ET100238.69
12:20 ET800238.35
12:21 ET508238.42
12:23 ET743237.995
12:25 ET400237.3725
12:27 ET100237.6275
12:30 ET309237.97
12:32 ET406238.145
12:36 ET300238.2
12:38 ET110237.9
12:39 ET408238.075
12:43 ET105238.105
12:45 ET915237.57
12:48 ET108237.735
12:50 ET390237.6
12:52 ET100237.115
12:54 ET205236.55
12:56 ET100236.9
12:57 ET530236.795
12:59 ET100236.78
01:01 ET406236.69
01:03 ET100235.78
01:06 ET200236.68
01:10 ET312236.515
01:14 ET1288235.93
01:15 ET100235.78
01:17 ET313235.54
01:26 ET400236.5425
01:28 ET411236.58
01:32 ET200236.885
01:33 ET300236.65
01:39 ET200236.485
01:42 ET105236.485
01:44 ET260236.16
01:46 ET210235.275
01:48 ET100234.97
01:57 ET100235.415
02:02 ET600235.505
02:15 ET100235.23
02:20 ET100235.16
02:29 ET100235.36
02:44 ET216235.72
02:45 ET400236.085
02:47 ET350235.85
02:49 ET448235.865
02:56 ET100235.64
02:58 ET200235.645
03:00 ET391235.625
03:03 ET200236.13
03:05 ET400235.9
03:07 ET100235.4
03:12 ET100234.82
03:23 ET100234.31
03:30 ET112234.38
03:32 ET200235.03
03:38 ET600234.06
03:39 ET100234.26
03:41 ET100234.26
03:48 ET313234.3975
03:50 ET216233.89
03:52 ET500233.22
03:54 ET600234.2
03:56 ET600234.45
03:57 ET1143233.86
03:59 ET25001233.36
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMDGL
Madrigal Pharmaceuticals Inc
5.1B
-9.2x
---
United StatesBBIO
BridgeBio Pharma Inc
4.9B
-10.1x
---
United StatesRNA
Avidity Biosciences Inc
4.9B
-14.3x
---
United StatesIMVT
Immunovant Inc
4.3B
-15.2x
---
United StatesCRNX
Crinetics Pharmaceuticals Inc
4.3B
-14.1x
---
United StatesKRYS
Krystal Biotech Inc
5.6B
51.8x
---
As of 2024-09-17

Company Information

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.

Contact Information

Headquarters
200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
Phone
404-380-9263
Fax
302-655-5049

Executives

Independent Chairman of the Board
Julian Baker
President, Chief Executive Officer, Director
Bill Sibold
Chief Financial Officer, Senior Vice President
Mardi Dier
President of Research and Development, Chief Medical Officer, Director
Rebecca Taub
General Counsel
Shannon Kelley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.1B
Revenue (TTM)
$14.6M
Shares Outstanding
21.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.43
EPS
$-25.50
Book Value
$20.39
P/E Ratio
-9.2x
Price/Sales (TTM)
346.2
Price/Cash Flow (TTM)
---
Operating Margin
-3,622.65%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.